what are the risks of tirzepatide Benefits Injections Who Should Avoid Tirzepatide? Safety
Description
Percentage calculated among patients with available insulin documentation (n = 9)
The medication acts as a dual receptor agonist for GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors
Three variants proved to be significantly correlated, namely, rs966423 in non-coding RNA- DIRC3 (OR = 1.34, P = 1.310 9 ), rs2439302 membrane glycoprotein involved in cell signaling NRG1 (OR = 1.36, P = 2.010 9 ) and rs116909374 in thyroid-specific transcription factor NKX21 (OR = 2.09, P = 4.610 11 ), and their functions in thyroid tumorigenesis are still unknown
doi: 10.1080/09637486.2017.1417978
346 Vanhaverbeke, G
